ZA933021B - Recombinant stimulating factor of the neu receptor - Google Patents

Recombinant stimulating factor of the neu receptor

Info

Publication number
ZA933021B
ZA933021B ZA933021A ZA933021A ZA933021B ZA 933021 B ZA933021 B ZA 933021B ZA 933021 A ZA933021 A ZA 933021A ZA 933021 A ZA933021 A ZA 933021A ZA 933021 B ZA933021 B ZA 933021B
Authority
ZA
South Africa
Prior art keywords
stimulating factor
neu receptor
recombinant
recombinant stimulating
neu
Prior art date
Application number
ZA933021A
Other languages
English (en)
Inventor
Duanzhi Wen
Elior Peles
Yosef Yarden
Original Assignee
Amgen Inc A Legal Body Organis
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc A Legal Body Organis, Yeda Res & Dev filed Critical Amgen Inc A Legal Body Organis
Publication of ZA933021B publication Critical patent/ZA933021B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA933021A 1992-04-29 1993-04-29 Recombinant stimulating factor of the neu receptor ZA933021B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87743192A 1992-04-29 1992-04-29

Publications (1)

Publication Number Publication Date
ZA933021B true ZA933021B (en) 1993-11-12

Family

ID=25369947

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933021A ZA933021B (en) 1992-04-29 1993-04-29 Recombinant stimulating factor of the neu receptor

Country Status (11)

Country Link
EP (1) EP0583050A3 (de)
JP (1) JPH07506488A (de)
KR (1) KR950701379A (de)
CN (1) CN1080959A (de)
AU (1) AU4228693A (de)
CA (1) CA2134564A1 (de)
FI (1) FI945085A0 (de)
MX (1) MX9302475A (de)
NO (1) NO944112L (de)
WO (1) WO1993022424A1 (de)
ZA (1) ZA933021B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7135456B1 (en) 1991-04-10 2006-11-14 Acorda Therapeutics, Inc. Glial mitogenic factors, their preparation and use
US7319019B1 (en) 1991-04-10 2008-01-15 Acorda Therapeutics, Inc. Glial mitogenic factors lacking an N-terminal signal sequence
US7285531B1 (en) 1991-04-10 2007-10-23 Acorda Therapeutics, Inc. Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor
US7094749B1 (en) 1991-04-10 2006-08-22 Acorda Therapeutics, Inc. Glial mitogenic factors, their preparation and use
US5834229A (en) 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US5367060A (en) * 1991-05-24 1994-11-22 Genentech, Inc. Structure, production and use of heregulin
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin
WO1994028133A1 (en) * 1993-05-21 1994-12-08 Amgen Inc. Recombinant neu differentiation factors
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US5633161A (en) 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
AU727606B2 (en) * 1996-07-12 2000-12-14 Genentech Inc. Gamma-heregulin
DE69840699D1 (de) * 1997-02-10 2009-05-14 Genentech Inc Heregulin varianten
US6136558A (en) * 1997-02-10 2000-10-24 Genentech, Inc. Heregulin variants
US20010023241A1 (en) 1998-02-04 2001-09-20 Sliwkowski Mark X. Use of heregulin as a growth factor
CA2455830C (en) * 2001-07-31 2012-10-09 Wayne State University Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
SG10201405107YA (en) 2006-02-23 2014-10-30 Viacyte Inc Compositions and methods useful for culturing differentiable cells
EP2356213B1 (de) 2008-11-04 2019-05-29 Viacyte, Inc. Stammzellenaggregat-suspensionszusammensetzungen und verfahren zur differenzierung davon
AU2013248265B2 (en) 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO921040L (no) * 1991-03-17 1992-09-18 Yeda Res & Dev Stimulerende faktor for neu-reseptoren
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin

Also Published As

Publication number Publication date
CA2134564A1 (en) 1993-11-11
AU4228693A (en) 1993-11-29
KR950701379A (ko) 1995-03-23
WO1993022424A1 (en) 1993-11-11
CN1080959A (zh) 1994-01-19
EP0583050A3 (de) 1994-10-05
EP0583050A2 (de) 1994-02-16
FI945085A7 (fi) 1994-10-28
NO944112L (no) 1994-12-29
MX9302475A (es) 1994-05-31
JPH07506488A (ja) 1995-07-20
FI945085L (fi) 1994-10-28
NO944112D0 (no) 1994-10-28
FI945085A0 (fi) 1994-10-28

Similar Documents

Publication Publication Date Title
GB9221654D0 (en) Recombinant human anti-cytomegalovirus antibodies
OA09879A (en) Recombinant antibodies for human therapy
IL106732A0 (en) Human interleukin-13
NO944112D0 (no) Rekombinat stimuleringsfaktor for neu-reseptoren
ZA936097B (en) Human interleukin-13
AU1298392A (en) Stimulating factor of the neu receptor
IL97005A0 (en) Recombinant human anti-cd18 antibodies
EP0438312A3 (en) Recombinant human anti-cd18 antibodies
GB2264948B (en) Human adenosine receptors
AU4377793A (en) Alternative receptor therapy
ZA936811B (en) Somatotropin modifications
GB9225467D0 (en) Aircraft construction
GB9222985D0 (en) Use of the tarchonanthus camphoratus
AU5669694A (en) Antagonists of human gamma interferon
ZA921944B (en) Stimulating factor of the neu receptor
ZA925615B (en) Recombinant antibodies for human therapy
KR950000006Y1 (en) Fastenings of sport-shoes
GB9304708D0 (en) Human neurokinin-3 receptor
EP0553954A3 (en) Preparation of tetramethyldiamino-polyoxyethylenes
EP0463571A3 (en) Recombinant human osteocalcin
GB9200368D0 (en) The 5-10 angulaversions of spacecraft
GB9223769D0 (en) Receptor cloning
GB9212427D0 (en) Receptor cloning
GB9217704D0 (en) Peptides for the treatment of malaria
GB9306043D0 (en) Human steroid hormone receptor nuci